Jackson Creek Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-748
Closed -$578K 401
2026
Q1
$578K Sell
748
-7
-0.9% -$5.36K 0.17% 186
2025
Q4
$583K Buy
+755
New +$513K 0.17% 186
2025
Q1
Sell
-476
Closed -$339K 364
2024
Q4
$339K Hold
476
0.1% 269
2024
Q3
$500K Sell
476
-45
-9% -$50.1K 0.15% 224
2024
Q2
$548K Sell
521
-25
-5% -$24.2K 0.2% 219
2024
Q1
$526K Sell
546
-127
-19% -$121K 0.19% 240
2023
Q4
$591K Sell
673
-23
-3% -$18.9K 0.23% 222
2023
Q3
$573K Sell
696
-76
-10% -$59.7K 0.24% 210
2023
Q2
$555K Sell
772
-729
-49% -$562K 0.22% 224
2023
Q1
$1.23M Sell
1,501
-1
-0.1% -$754 0.52% 18
2022
Q4
$1.08M Sell
1,502
-173
-10% -$128K 0.48% 17
2022
Q3
$1.15M Sell
1,675
-14
-0.8% -$8.81K 0.54% 11
2022
Q2
$982K Buy
1,689
+709
+72% +$461K 0.4% 108
2022
Q1
$684K Sell
980
-909
-48% -$575K 0.25% 202
2021
Q4
$1.19M Buy
1,889
+522
+38% +$321K 0.43% 71
2021
Q3
$827K Sell
1,367
-44
-3% -$27.3K 0.31% 182
2021
Q2
$788K Sell
1,411
-2
-0.1% -$1.01K 0.29% 188
2021
Q1
$669K Buy
1,413
+46
+3% +$22.4K 0.23% 213
2020
Q4
$660K Sell
1,367
-7
-0.5% -$3.78K 0.26% 208
2020
Q3
$769K Buy
+1,374
New +$833K 0.35% 139

Other funds holding REGN

Jackson Creek Investment Advisors's REGN Position: Q2 2026 in Review

Jackson Creek Investment Advisors sold out of Regeneron Pharmaceuticals (REGN) in Q2 2026, closing a stake of 748 shares — an estimated $578K sold.

Jackson Creek Investment Advisors first reported a position in REGN in Q3 2020 and held it in 20 quarters. The position peaked at $1.23M in Q1 2023. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Jackson Creek Investment Advisors reported no remaining Regeneron Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jackson Creek Investment Advisors sold 748 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $578K.
  • Jackson Creek Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q3 2020 and held it in 20 quarters.
  • Jackson Creek Investment Advisors's Regeneron Pharmaceuticals position peaked at $1.23M in Q1 2023.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.